Skip to content

← All developments

South Dakota Attorney General · October 1, 2026 · Primary source

Attorney General Jackley Requests Court Approval Of South Dakota Settlement with Sandoz Inc.

Score 63PRIMARYregulatoryState AGSD

Summary

South Dakota Attorney General Marty Jackley announced that South Dakota has joined 42 other states and territories in seeking preliminary federal court approval of a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. resolving antitrust allegations that the companies conspired to artificially inflate and manipulate prices for numerous generic prescription drugs. South Dakota's state share is $389,077.51, of which a portion goes to the South Dakota Medicaid Program. The settlement is part of the broader multi-state generic drug price-fixing litigation ongoing since 2016, with consumer claims available for generic drug purchases made between May 2009 and December 2019.

What this may mean

The $400 million Sandoz and Fougera settlement, pending preliminary federal court approval, directs a portion of South Dakota's recovery to the state Medicaid program, which was overcharged for generic drugs during the covered period. The settlement includes injunctive terms requiring internal reforms at the settling companies to ensure antitrust compliance going forward.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items